Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

History

Blood-Based Biomarkers

Transcriptional measur

See All (2) pages

Contact Us
If you have any questions or feedback please contact us.

Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer.

Camidge DR, Schenk EL. Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer. Cell. 2020 10 15; 183(2):303-304.

View in: PubMed

subject areas

authors with profiles

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)